Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats
Authors:
Open Access
- 1 March 2017
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 12, 2117-2127
Abstract
The blood–brain barrier is a formidable obstacle for glioma chemotherapy due to its compact structure and drug efflux ability. In this study, a dual-targeting drug delivery system involving Angiopep-2-conjugated biodegradable polymersomes loaded with doxorubicin (Ang-PS-DOX) was developed to exploit transport by the low-density lipoprotein receptor-related protein 1 (LRP1), which is overexpressed in both blood–brain barrier and glioma cells. The polymersomes (PS) were prepared using a thin-film hydration method. The PS were loaded with doxorubicin using the pH gradient method (Ang-PS-DOX). The resulting PS were uniformly spherical, with diameters of ~135 nm and with ~159.9 Angiopep-2 molecules on the surface of each PS. The drug-loading capacity and the encapsulation efficiency for doxorubicin were 7.94%±0.17% and 95.0%±1.6%, respectively. Permeability tests demonstrated that the proton diffusion coefficient across the PS membrane was far slower than that across the liposome membrane, and the common logarithm value was linearly dependent on the dioxane content in the external phase. Compared with PS-DOX, Ang-PS-DOX demonstrated significantly higher cellular uptake and stronger cytotoxicity in C6 cells. In vivo pharmacokinetics and brain distribution experiments revealed that Ang-PS-DOX achieved a more extensive distribution and more abundant accumulation in glioma cells than PS-DOX. Moreover, the survival time of glioma-bearing rats treated with Ang-PS-DOX was significantly prolonged compared with those treated with PS-DOX or a solution of free doxorubicin. These results suggested that Ang-PS-DOX can target glioma cells and enhance chemotherapeutic efficacy.Keywords
This publication has 42 references indexed in Scilit:
- Early stage intercalation of doxorubicin to DNA fragments observed in molecular dynamics binding simulationsJournal of Molecular Graphics and Modelling, 2012
- Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat ModelPLOS ONE, 2012
- Lactoferrin-Conjugated Biodegradable Polymersome Holding Doxorubicin and Tetrandrine for Chemotherapy of Glioma RatsMolecular Pharmaceutics, 2010
- Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiformeBiomaterials, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- [Lipoproteins and their receptors in the central nervous system].2009
- Blood–brain barrier deliveryDrug Discovery Today, 2007
- Drug permeability across a phospholipid vesicle-based barrierEuropean Journal of Pharmaceutical Sciences, 2006
- THE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILYAnnual Review of Nutrition, 1999
- Brain drug delivery of small molecules using immunoliposomesProceedings of the National Academy of Sciences, 1996